Publication Type Journal Article
Title Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients
Authors Pablo Labarga Jose Medrano Eduardo Seclen Eva Poveda Sonia Rodriguez-Novoa Judit Morello Carmen de Mendoza Eugenia Vispo Vincent Soriano
Groups
Journal AIDS
Year 2010
Month March
Volume 24
Number 5
Pages 777-779
Abstract All 178 HIV-infected individuals who had initiated tenofovir-emtricitabine-nevirapine (TDF/FTC/ NVP) at our institution and were adherent to their medication were retrospectively examined. Only 22\% were antiretroviral naive. After a median follow-up of 16 months, only five (2.8\%) individuals (all with prior exposure to other antiretroviral regimens) experienced virological failure. In all instances, viral rebound occurred after 12 weeks of therapy. These results do not support an increased risk of early virological failure using TDF/FTC/NVP.
DOI http://dx.doi.org/10.1097/QAD.0b013e3283322895
ISBN
Publisher
Book Title
ISSN 0269-9370
EISSN
Conference Name
Bibtex ID ISI:000275148900020
Observations
Back to Publications List